IPO Archives - Pharmaphorum

Alector kicks off biotech IPOs after US government shutdown

https://pharmaphorum.com/news/alector-kicks-off-biotech-ipos-after-us-government-shutdown/

Moderna shares slide after record $604m US listing

https://pharmaphorum.com/news/moderna-shares-slide-after-record-604m-us-listing/

Secretive Moderna could finally go public with $500m IPO

https://pharmaphorum.com/news/secretive-moderna-could-finally-go-public-with-500m-ipo/

UK biotech Orchard plans $172.5m US IPO to fund rare disease R&D

https://pharmaphorum.com/news/uk-biotech-orchard-plans-172-5m-us-ipo-to-fund-rare-disease-rd/

UK biotech riding on crest of VC funding wave – report

https://pharmaphorum.com/news/uk-biotech-riding-on-crest-of-vc-funding-wave-report/

Cancer blood test firm Grail mulls IPO

https://pharmaphorum.com/news/cancer-blood-test-firm-grail-mulls-hong-kong-ipo/

Apitope announces IPO to fund MS drug development

https://pharmaphorum.com/news/apitope-announces-ipo-fund-ms-drug-development/

Biofrontera mulls US IPO to fund skin cancer drug

https://pharmaphorum.com/news/biofrontera-considers-us-listing-fund-skin-cancer-drug/

Clovis looks for new drugs after Rubraca success

https://pharmaphorum.com/news/clovis-looks-new-drugs-rubraca-success/

Search